DNA GINKGO BIOWORKS HOLDINGS CLASS A
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 6 analyst firms say about GINKGO BIOWORKS HOLDINGS CLASS A: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
4 rated views · 6 analyst/firm records · 6 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
- Russell 2000 · Safest consensus · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
Recent analyst activity · last 90 days
Our tracked history has 5 reports on DNA from 5 analyst firms in the last 90 days (6 firms in the past year).
Comparing each firm's latest target with its previous one: 1 lowered it, 1 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: TD Cowen lowered its target from $12.00 (set 8 Jan 2026) to $11.00 on 13 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| BTIG | Mark Massaro | Sell | 4 Sep 2026 | 5.00 USD |
| Oppenheimer | Unnamed analyst | — | 9 Sep 2026 | 5.00 USD |
| TD Cowen | Brendan Smith | Hold | 13 Oct 2026 | 11.00 USD |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| William Blair | Jared Haase | Sell | 5 Aug 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 17 Aug 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:17 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.